RBC Europe’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.37M | Buy |
3,916
+316
| +9% | +$111K | 0.07% | 94 |
|
|
2022
Q1 | $1.97M | Buy |
3,600
+568
| +19% | +$311K | 0.08% | 86 |
|
|
2021
Q4 | $2M | Sell |
3,032
-2,311
| -43% | -$1.52M | 0.09% | 82 |
|
|
2021
Q3 | $3.32M | Buy |
5,343
+151
| +3% | +$93.9K | 0.14% | 85 |
|
|
2021
Q2 | $3.28M | Buy |
5,192
+54
| +1% | +$34.1K | 0.15% | 89 |
|
|
2021
Q1 | $2.51M | Buy |
5,138
+113
| +2% | +$55.3K | 0.14% | 98 |
|
|
2020
Q4 | $2.51M | Buy |
5,025
+499
| +11% | +$249K | 0.14% | 92 |
|
|
2020
Q3 | $1.78M | Buy |
4,526
+3,825
| +546% | +$1.5M | 0.12% | 97 |
|
|
2020
Q2 | $231K | Sell |
701
-9,065
| -93% | -$2.99M | 0.02% | 219 |
|
|
2020
Q1 | $2.37M | Buy |
9,766
+60
| +0.6% | +$14.5K | 0.24% | 66 |
|
|
2019
Q4 | $2.53M | Hold |
9,706
| – | – | 0.22% | 78 |
|
|
2019
Q3 | $2.64M | Sell |
9,706
-575
| -6% | -$156K | 0.26% | 74 |
|
|
2019
Q2 | $2.83M | Hold |
10,281
| – | – | 0.28% | 68 |
|
|
2019
Q1 | $2.3M | Buy |
10,281
+575
| +6% | +$129K | 0.25% | 75 |
|
|
2018
Q4 | $1.81M | Buy |
9,706
+1,520
| +19% | +$283K | 0.24% | 77 |
|
|
2018
Q3 | $2.04M | Hold |
8,186
| – | – | 0.23% | 77 |
|
|
2018
Q2 | $1.78M | Sell |
8,186
-990
| -11% | -$216K | 0.21% | 82 |
|
|
2018
Q1 | $1.76M | Sell |
9,176
-65
| -0.7% | -$12.4K | 0.21% | 87 |
|
|
2017
Q4 | $1.45M | Buy |
9,241
+4,866
| +111% | +$761K | 0.18% | 97 |
|
|
2017
Q3 | $680K | Buy |
+4,375
| New | +$680K | 0.09% | 128 |
|